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It is well known that a chronic state of elevated reactive oxygen species (ROS) in pancreatic β-cells impairs their ability to release
insulin in response to elevated plasma glucose. Moreover, at its extreme, unmitigated ROS drives regulated cell death. This
dysfunctional state of ROS buildup can result both from genetic predisposition and environmental factors such as obesity and
overnutrition. Importantly, excessive ROS buildup may underlie metabolic pathologies such as type 2 diabetes mellitus. The
ability to monitor ROS dynamics in β-cells in situ and to manipulate it via genetic, pharmacological, and environmental means
would accelerate the development of novel therapeutics that could abate this pathology. Currently, there is a lack of models with
these attributes that are available to the field. In this study, we use a zebrafish model to demonstrate that ROS can be generated
in a β-cell-specific manner using a hybrid chemical genetic approach. Using a transgenic nitroreductase-expressing zebrafish
line, Tg(ins:Flag-NTR)s950, treated with the prodrug metronidazole (MTZ), we found that ROS is rapidly and explicitly generated
in β-cells. Furthermore, the level of ROS generated was proportional to the dosage of prodrug added to the system. At high
doses of MTZ, caspase 3 was rapidly cleaved, β-cells underwent regulated cell death, and macrophages were recruited to the islet
to phagocytose the debris. Based on our findings, we propose a model for the mechanism of NTR/MTZ action in transgenic
eukaryotic cells and demonstrate the robust utility of this system to model ROS-related disease pathology.
1. Introduction
The generation of reactive oxygen species (ROS)—including
peroxides, superoxides, and oxygen radicals—in excess of
ROS mitigation mechanisms, results in cellular dysfunction
and triggers regulated cell death under extreme circum-
stances [1]. Cells of metabolically active tissues are predis-
posed to high levels of ROS production, and thus, metabolic
diseases such as type 2 diabetes mellitus (T2DM) are often
associated with excessive ROS generation and resulting
oxidative stress [2]. T2DM is characterized by chronic
hyperglycemia resulting from the dysfunction of insulin-
secreting pancreatic β-cells in the setting of overnutrition
and obesity [3]. This dysfunction may be driven in part
by the generation of excessive ROS, which likely results
from the low endogenous levels of antioxidant enzymes
in β-cells [4]. ROS diminishes the expression of insulin
in β-cells, impairs glucose-stimulated insulin secretion,
and promotes β-cell apoptosis [5, 6]. The availability of
a vertebrate model to study factors that regulate ROS
dynamics in the islet in situ would accelerate the discov-
ery and testing of novel therapeutics for a variety of met-
abolic diseases, including T2DM. The zebrafish, Danio
rerio, is a robust model to interrogate the pathogenesis
of metabolic disease and the efficacy of experimental ther-
apeutics [7, 8].
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The oxygen-insensitive NAD(P)H nitroreductase (NTR,
NfsB) enzyme, cloned from E. coli, has been harnessed to
drive tissue-specific cell ablation in various transgenic zeb-
rafish models. When NTR-expressing transgenic zebrafish
lines, such as Tg(ins:Flag-NTR)s950, are treated with the
antibiotic metronidazole (MTZ), this prodrug is metabo-
lized into cytotoxins that are retained by NTR-expressing
β-cells, rapidly inducing their death [9]. While the precise
mechanisms of MTZ-induced cell toxicity have not been
characterized in NTR-expressing transgenic lines, existing
research provides some insight: nitroreduction of MTZ may
produce cytotoxic nitroradical metabolites, which can cross-
link DNA [10–12]. In this study, we use transgenic NTR+
zebrafish to demonstrate their suitability for modeling ROS
generation, cellular responses to ROS, and pharmaceutical
interventions in vivo. Together, our findings suggest that
zebrafish are a superb model for ROS-related disorders.
2. Results
2.1. Metronidazole Induces β-Cell ROS Generation in an
NTR- and Dose-Dependent Manner. The nitroreductase-
metronidazole (NTR-MTZ) system has been widely imple-
mented as a tool to efficiently ablate cells in a tissue-specific
and temporally controllable manner [13]. However, the
molecular mechanisms driving its induction of regulated cell
death are not fully understood. To determine if ROS are
generated in MTZ-treated NTR-expressing cells, we used
Tg(ins:Flag-NTR)s950 transgenic zebrafish that express insulin
promoter-driven NTR in the pancreatic β-cells. Heterozy-
gous transgenic larvae were immersed in a solution of MTZ
for 0, 1, 3, 6, 12, or 24hr, then stained with CellROX green
to indicate ROS (Figure 1(a)). Incubation start times were
staggered such that all larvae were at 106 hours postfertiliza-
tion (hpf) at analysis. We began treatments with 7.5mM
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Figure 1: Time-dependent metronidazole induction of β-cell-specific ROS. (a) Schematic of MTZ treatments and imaging. Zebrafish (NTR+)
larvae were treated with MTZ or vehicle for 0, 1, 3, 6, 12, or 24 hours with a “staggered start” such that all treatments were completed
simultaneously; larvae were then incubated with CellROX green stain at 105 hpf and fixed/analyzed at 106 hpf. (b) Representative
immunofluorescence images of zebrafish pancreatic islets stained with insulin antibody and CellROX green after 7.5mM MTZ treatments.
Magnified insets (bounded by dashed boxes) highlight the dose-dependent increase in CellROX green signal in β-cells. (c) Quantification
of CellROX green intensity in insulin-positive β-cells showing a significant increase in ROS generation after 1, 3, 6, and 12 hours of MTZ
treatment as compared to vehicle-treated controls (n = 12 for each condition). (d) MTZ treatment caused a significant decrease in β-cell
area after 12 or 24 hours of treatment as compared to untreated controls. (e) Representative immunofluorescence images of zebrafish
pancreatic islets treated for 3 hours with 0 or 7.5mM MTZ and stained with 5 μM DHE. Dotted lines demarcate the boundaries of the
pancreas. Graphed data are presented as mean± SEM (∗p < 0 05). Statistical significance was determined by one-way ANOVA followed by
post hoc Holm-Sidak test. Scale bar indicates 10 μm.
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MTZ, a dose which is effective to ablate β-cells after 24 hr
exposure [14]. With 1 hour of treatment, we observed ROS
staining specifically in β-cell nuclei, whereas adjacent islet
cells were not stained (Figure 1(b)). With longer treatments,
ROS levels increased by almost 4-fold relative to untreated
controls, reaching a peak intensity with 6 hours of treatment,
then showing less increase with 12 or 24 hours of treatment
(Figure 1(c)). We attribute this diminished staining to the
attrition of β-cells via regulated cell death mechanisms and
their clearance by phagocytes (Figure 1(d)), as well as the
neogenesis of β-cells that have not yet generated detectable
ROS. Importantly, neither MTZ nor the transgene was
toxic alone; ROS generation in β-cells required both com-
ponents ([9], data not shown). To further confirm that the
CellROX green staining that we observed was truly repre-
sentative of MTZ-induced cellular ROS and not artefactual
(i.e., simply due to an interaction of CellROX green with
the reduced nitroradical form of metronidazole), we next
incubated MTZ-treated transgenic larvae in 5μM dihy-
droethidium (DHE). Upon its oxidation to 2OH-ethidium
by superoxide, this cell-permeant dye is excited at 405 nm
and emits a bright red fluorescence at 570nm [15]. In
106hpf Tg(ins:Flag-NTR)s950 larvae that were not treated
with MTZ, we detected no specific pancreatic fluorescence
in any sample (Figure 1(e); n = 13). In contrast, in transgenic
larvae treated with 7.5mM MTZ for 3 hours, we observed
strong fluorescence in β-cells in every case (Figure 1(e);
n = 14). These data indicate that superoxide is generated
in transgenic β-cells in response to MTZ.
Next, we hypothesized that the level of ROS generated in
the NTR+ β-cells would be directly dependent on the concen-
tration of MTZ present. To investigate if there is a dose-
dependent relationship, we treated embryos with both low
(2.5mM) and high (7.5mM) concentrations of MTZ using
the same experimental paradigm indicated in Figure 1(a).
As expected, there was no ROS generation in the untreated
control β-cells (Figure 2(a)). With 1 hour of treatment, the
2.5mM dose did not show significant ROS generation, but
7.5mM MTZ induced a more than 4-fold increase in ROS
levels as compared to untreated controls (Figures 2(b)–
2(d)). With 6 hours of treatment, the 2.5mM treatment did
not result in significant ROS generation, though it trended
upward, while the 7.5mM dose caused a nearly 6-fold rise
in ROS levels relative to untreated controls. Consistent with
our previous observations, the measured ROS levels were
no different than baseline with 24-hour treatment of either
the 2.5mM or 7.5mM MTZ. Despite the lower levels of
ROS observed with 2.5mM treatment, there was a dramatic
reduction in the number of β-cells at the 24-hour time point
(Figure 1(b)). Thus, even though induced ROS levels are
lower with the 2.5mM dose, this dose is sufficient to induce
cell death over a 24-hour period.
2.2. MTZ-Induced ROS Generation Leads to Immune Cell
Recruitment and β-Cell Apoptosis. Many studies have corre-
lated the production of ROS with the induction of apoptotic
cell death [15–17]. Therefore, to determine whether the
generation of ROS is correlated with the induction of β-cell
apoptosis in this system, we analyzed cleaved caspase 3
(Casp3∗) in islet β-cells after following the same MTZ treat-
ment paradigm shown in Figure 1(a). Casp3∗ is the active
form of caspase 3 and an indicator of the activated apoptotic
pathway. We did not detect significant Casp3∗ staining in
the untreated controls or with a 1-hour MTZ treatment
(Figures 3(a)–3(d)). However, with a 6-hour treatment,
Casp3∗ was significantly increased with 7.5mM MTZ, but
not 2.5mM relative to untreated controls, following a pattern
similar to ROS generation (Figures 2(d) and 3(d)). As before,
with 24 hours of treatment, almost all β-cells were ablated by
both concentrations of MTZ (Figures 3(b) and 3(c)).
It has been demonstrated that ROS-injured β-cells
release factors that attract immune cells [18]. Consistent with
this finding, we show that generation of ROS in β-cells is
coincident with the infiltration of Tg(mpeg1:GFP) +macro-
phages into the islet; this is first apparent with a 3-hour
treatment, and peak infiltration is seen with 6 hours of
MTZ treatment—when the ROS staining was also measured
at its highest levels. Additionally, engulfment of β-cells by
macrophages is first observed with a 12-hour MTZ treat-
ment, a time point that is coincident with the observed drop
in the β-cell area (Figures 1(d) and 3(e)).
2.3. Antioxidants Protect β-Cells from MTZ-Induced ROS
Generation. We hypothesized that the generation of ROS in
β-cells could be mitigated in our zebrafish model by the
addition of small molecule antioxidants to the water. To test
this hypothesis, we used the common antioxidant N-acetyl-
L-cysteine (NAC). We treated zebrafish larvae with an inter-
mediate dose of 5mMMTZ with the goal of using a dose that
was strong enough to induce a rapid ROS response, but that
would not overwhelm other treatments. MTZ treatments
were supplemented with 100μM NAC and ROS intensity
was measured at multiple time points (Figure 4). With either
a 1- or 6-hour treatment of MTZ, NAC significantly reduced
the levels of ROS staining in β-cells. Consistent with all other
treatments, there was no significant difference with a 24-hour
treatment, which again could be attributed to the ablation of
nearly all β-cells in the presence of MTZ treatment alone.
Together, we conclude that MTZ drives the production of
ROS in β-cells in the presence of NTR. Additionally, a known
antioxidant was effective at mitigating this effect, suggesting
that other novel compounds might be uncovered through
screening approaches in this zebrafish system.
3. Discussion
3.1. Mechanism of Cell Ablation by MTZ-NTR.NTR (NfsB) is
a type 1 oxygen-insensitive nitroreductase that catalyzes the
full reduction of nitroaromatic compounds under anaerobic
conditions [19]. In anaerobes, MTZ serves as a prodrug that
is metabolized by NTR to generate cytotoxic derivatives
capable of blocking DNA synthesis and inducing DNA
damage [20]. In our study, we found that MTZ also induces
ROS generation in the presence of NTR. This is consistent
with the hypothesis that under aerobic conditions, as when
expressed in mammalian cells, NTR might generate super-
oxide and derivative reactive oxygen species, potentially
through a type 2-like “futile reduction cycle” (Figure 5) [21].
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3.2. Utility of MTZ-NTR Zebrafish System as a Disease Model
beyond Just Cell Ablation. As a β-cell ablation system, the
relevance of Ins:NTR/MTZ to type 1 diabetes is evident.
However, chronic ROS production and associated β-cell dys-
function are also critical to the pathology of type 2 diabetes
even before β-cell mass is diminished. Intriguingly, because
the generation of ROS by NTR in this model is dependent
on the dose of MTZ treatment, this provides a compelling
opportunity to manipulate ROS under varied contexts.
For instance, many other disease conditions like type 2 dia-
betes, atherosclerosis, diabetic neuropathy, and cancer arise
as a result of chronic ROS generation in specific tissues
[22]. To model such cases, low concentrations of MTZ
can be used for generating persistent ROS conditions and
studying the effects. Future studies will determine whether
lower levels of ROS can be induced by MTZ treatments
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Figure 2: Metronidazole induces ROS generation in a dose-dependent manner. (a) Representative image of vehicle-treated zebrafish islets
(n = 12) at 106 hpf. (b) Representative image of islets of zebrafish (NTR+) larvae (n = 12 per condition) treated with 2.5mM and 7.5mM
MTZ at different time points. (c) Quantification of CellROX intensity shows a significant increase after 1 or 6 hours of treatment in the
β-cells of 7.5mM MTZ-treated embryos, as compared to untreated controls. Data are presented as mean± SEM (∗p < 0 05). Statistical
significance was determined by one-way ANOVA followed by post hoc Holm-Sidak test. Scale bar indicates 10 μm.
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that are sufficient to impair β-cell function, but not to
induce cell death.
Zebrafish proves to be an outstanding model organism
for studying ROS generation and ROS-related pathologies.
The MTZ-NTR system seems to work exceptionally well for
cell-specific ablation. However, with the added possibility of
precisely modulating the ROS generation using MTZ dosing
and antioxidants like NAC, this makes zebrafish a particu-
larly flexible model.
4. Methods
4.1. Zebrafish Maintenance and Embryo Collection. Wild-
type (AB), Tg(ins:Flag-NTR)s950 (ZDB-ALT-130930-5) [23],
and Tg(mpeg1:GFP) (ZDB-ALT-120117-1) zebrafish were
maintained at 28.5°C in a recirculating aquaculture sys-
tem enclosed in a cabinet and subjected to a 14-/10-hour
light/dark cycle in accordance with institutional policies
under IACUC oversight. Heterozygous outcrossed embryos
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Figure 3: Metronidazole induces apoptosis signaling in β-cells. (a) Representative image of vehicle-treated zebrafish islets (n = 12) after fixing
at 106 hpf. (b) Representative image of islets of zebrafish (NTR+) larvae (n = 12 per condition) treated with 2.5mM or 7.5mM MTZ at
different time points and immune-stained for insulin and cleaved caspase 3 (Casp3∗). (c) Quantification of Casp3∗ intensity shows a
significant increase after 6 hours of treatment in the β-cells of 7.5mM MTZ-treated embryos compared to vehicle. (d) Representative
immunofluorescence images of zebrafish (mpeg+) islets (N = 6/condition) treated with 7.5mM MTZ showing macrophage invasion into
islets (green arrows) and their engulfment of β-cells (yellow arrows). Data are presented as mean± SEM (∗p < 0 05). Statistical significance
was determined by one-way ANOVA followed by post hoc Holm-Sidak test. Scale bar indicates 10μm.
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bearing the Tg(ins:Flag-NTR)s950 allele were collected at
spawning and maintained in a 28.5°C incubator in egg
water-filled petri dishes. Transgenic zebrafish larvae were
genotyped by epifluorescence at 80 hpf using a Leica
M205FA dissecting microscope.
4.2. Chemical Treatments. 1-Phenyl-2-thiourea (PTU; Acros
#207250250) supplementation at 0.003% was used to prevent
pigmentation in all embryos after gastrulation stages. Metro-
nidazole (Sigma #095K093) solutions of 2.5mM, 5mM, and
7.5mM were prepared in egg water (0.1% instant ocean
salt, 0.0075% calcium sulfate) that was supplemented with
PTU. For antioxidant treatments, egg water, either with or
without 5mMMTZ,was supplementedwith 100μMN-acetyl
L-cysteine (NAC; Acros #160280250), which was diluted
from a 100mM stock prepared in ddH2O. Control treatments
for MTZ and NAC used egg water alone.
4.3. ROS Staining, Immunofluorescence, and Image
Collection. Cellular ROS was detected using a CellROX green
reagent (Invitrogen #C10444); live larvae were transferred to
1.5ml microcentrifuge tubes, washed with egg water, then
incubated in the dark for 1 hr at 28.5°C with 10μM CellROX
green diluted in egg water. At the conclusion of each experi-
ment, larvae were washed in egg water then fixed with 3%
formaldehyde in a PEM buffer (0.21M PIPES, 1mMMgSO4,
2mM EGTA, and pH7) at 4°C overnight. Fixed larvae were
washed with PBS and deyolked, then antibody staining
was performed as described [24]. The following concen-
trations of primary antibodies were used: 1 : 200 guinea
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Figure 4: Antioxidant treatment protects from metronidazole-induced ROS generation in β-cells. Zebrafish larvae (n = 12 per condition)
were treated with 5mM metronidazole±N-acetyl-L-cysteine (NAC) for 1, 6, or 24 hours followed by an assessment of ROS using
CellROX green stain. (a) Representative images of islets of 106 hpf zebrafish (NTR+) embryos treated with 5mM MTZ±NAC at different
time points. (b) Quantification of CellROX green intensity shows NAC-mediated protection from MTZ-induced ROS in β-cells after 1 or
6 hours of treatment. Data are presented as mean± SEM (∗p < 0 05). Statistical significance was determined by Student’s t-test. Scale bar
indicates 10 μm.
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Figure 5: Proposed mechanism of metronidazole-nitroreductase-
mediated cell ablation. In the aerobic setting of NTR-expressing
eukaryotic cells, we propose that MTZ is reduced to a nitroradical
anion by electron transfer from NADH, in a type 2-like mechanism.
This radical may be cytotoxic and directly induces DNA damage
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pig anti-insulin (Invitrogen #180067), 1 : 200 rabbit anti-
cleaved caspase 3 (Cell Signaling Technologies #9661S),
and 1 : 100 mouse anti-glucagon (Sigma #SAB4200685). Pri-
mary antibodies were detected with 1 : 500 dilutions of com-
plementary Alexa-conjugated secondary antibodies (Jackson
ImmunoResearch). DNA was stained with TO-PRO3
(Thermo Fisher #T3605) diluted 1 : 500. After staining, larvae
were mounted on slides in VECTASHIELD (Vector Labs
H-1000), and confocal imaging was performed with a Zeiss
LSM700 microscope. The confocal stacks of pancreatic
islets were analyzed with CellProfiler software [25]. For
detection of superoxide in situ in live pancreatic β-cells,
heterozygous Tg(ins:Flag-NTR)s950 larvae were treated with
7.5mM MTZ for 3 hours then placed in 5μM dihydroethi-
dium (Thermo Fisher #D1168) + 0.02% DMSO for 30
minutes in dark conditions. Larvae were then paralyzed
with 0.01% tricaine (Sigma #A-5040), mounted on glass-
bottom petri dishes (Mattek #P35G-0-10-C) in 0.5% low
melt agarose (Sigma #A9414), and imaged with a Zeiss
LSM700 confocal microscope.
4.4. Statistical Analysis. The data are presented as the
means± standard error of the mean (SEM). The data analy-
ses were performed using the GraphPad Prism 7.1 software
package. Significant differences between the mean values
were determined using Student’s t-test, where two means
were compared, and one-way analysis of variance (ANOVA)
followed by post hoc Holm-Sidak test when more than two
means were compared. The differences were considered
statistically significant at p < 0 05.
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